Unicharm (UNICY) AI Stock Analysis

• Market Cap: $10.50B
• Dividend Yield: N/A
• Average Volume (3M): 49.62K
• Price to Earnings (P/E): 82.6
• Beta (1Y): 0.08
• Revenue Growth: -0.81%
• EPS Growth: -0.63%
• Country: US
• Employees: 1,404
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): <0.01
• Shares Outstanding: 3,725,005,900
• 10 Day Avg. Volume: 33,046
• 30 Day Avg. Volume: 49,617
• PEG Ratio: -1.19
• Price to Book (P/B): 1.94
• Price to Sales (P/S): 1.55
• P/FCF Ratio: 14.29
• Enterprise Value/Market Cap: 128.99
• Enterprise Value/Revenue: 1.43
• Enterprise Value/Gross Profit: 3.75
• Enterprise Value/Ebitda: 8.10
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: $3.00 ▲(6.38% Upside)
• Action: Upgraded Date: 02/18/26
• Date: Action: Upgraded 02/18/26

The score is primarily supported by strong financial quality—particularly the conservative balance sheet and solid long-term growth—partly offset by recent margin/profitability pressure and inconsistent free cash flow. Technically, the uptrend is intact but overbought signals add near-term risk, while valuation looks elevated at ~27x earnings with no dividend yield provided.

Positive Factors

Conservative balance sheet

Very low leverage and falling total debt increase financial resilience. A conservative balance sheet gives Unicharm flexibility to absorb shocks, fund organic growth or selective M&A, and maintain operations during cycles without relying on costly external financing.

Recurring consumables business model

A consumables-heavy portfolio (baby, feminine, adult care, pet) creates repeat purchase dynamics and distribution stickiness. This structural demand pattern supports predictable revenues and stable unit volumes, aiding long-term planning and pricing power versus nonrecurring product businesses.

Improving cash generation in 2025

A material improvement in free cash flow increases internal funding capacity for capex, working capital, or shareholder returns. Consistently positive operating cash flow underpins financial flexibility and reduces dependence on external capital over the medium term.

Negative Factors

Margin and profitability pressure

Earnings compression despite top-line growth suggests rising input costs or deliberate reinvestment that dilute margins. Persistent margin pressure can erode returns on sales, limit re-investable cash, and reduce the firm's capacity to fund expansion or withstand pricing competition.

Volatile free cash flow / cash conversion

Inconsistent cash conversion and periodic FCF shortfalls complicate capital allocation. Volatility driven by working-capital swings or timing of investments increases execution risk and could force external financing during growth phases or limit predictable shareholder returns.

Limited asset-base expansion

A stagnating asset base may indicate constrained capacity for scaling manufacturing or distribution. Long-term growth reliant on efficiency rather than new assets could limit market share gains in high-growth regions or require outsourcing, which can compress margins or slow execution.

Unicharm Business Overview & Revenue Model

Company Description

Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Unicharm makes money primarily by selling branded disposable hygiene and care products to retail and wholesale channels (and, depending on market, e-commerce and institutional buyers). Its key revenue streams are (1) Baby Care: sales of disposable diapers and related childcare hygiene products; (2) Feminine Care: sales of sanitary napkins and related products; (3) Adult Care: sales of incontinence and elderly care hygiene products; and (4) Pet Care: sales of pet sheets, litter, and related consumables. Revenue is generated on a recurring, consumables basis—end users repurchase frequently—supporting steady volume-driven sales. Earnings are influenced by the company’s ability to maintain pricing and brand share, manage input and manufacturing costs, expand distribution, and grow in higher-growth overseas markets through local operations and, where applicable, regional partners and subsidiaries. If specific partnership counterparties or deal terms are required, null.

Unicharm Financial Statement Overview

Summary

Strong revenue growth (including a major 2025 step-up) and a very low-leverage balance sheet support a solid fundamental profile. Offsetting factors are profitability pressure (EBIT/EBITDA down in 2025 despite higher sales) and uneven cash conversion with volatile free cash flow.

Income Statement

Revenue has expanded steadily from 2020–2024 and then surged in 2025 (annual revenue growth ~35%), showing strong top-line momentum. Profitability is generally solid for the category (gross margin ~37–40% and net margin ~7–9% in 2020–2024). The main weakness is margin pressure and profit softness: net income fell in 2024 vs. 2023, and EBIT/EBITDA declined in 2025 versus 2024, suggesting higher costs or reinvestment is diluting earnings despite the revenue jump.

Balance Sheet

The balance sheet looks conservative with very low leverage: debt-to-equity stayed modest in 2020–2024 (~0.03–0.07) and total debt dropped meaningfully in 2025. Equity has grown consistently over the period, supporting resilience. A watch item is that total assets dipped slightly in 2024 and rose only marginally into 2025, implying growth is not being driven by a rapidly expanding asset base, but overall solvency and financial flexibility remain strong.

Cash Flow

Cash generation is healthy with operating cash flow consistently positive and free cash flow strong across the period, improving in 2025 (free cash flow growth ~64%). However, free cash flow has been volatile year-to-year (declines in 2021, 2022, and 2024), and in 2024 free cash flow covered only about 71% of net income, pointing to periodic working-capital or investment swings that can make cash conversion less predictable.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	991.09B	988.98B	941.79B	898.02B	782.72B
Gross Profit	373.10B	389.91B	351.53B	328.60B	313.64B
EBITDA	164.29B	185.00B	180.56B	161.16B	160.80B
Net Income	68.37B	81.84B	86.05B	67.61B	72.75B
Balance Sheet
Total Assets	1.22T	1.24T	1.13T	1.05T	987.65B
Cash, Cash Equivalents and Short-Term Investments	253.26B	353.94B	253.77B	307.60B	307.30B
Total Debt	11.06B	26.85B	28.57B	27.02B	38.31B
Total Liabilities	332.14B	366.26B	345.38B	340.61B	352.22B
Stockholders Equity	795.25B	773.06B	695.72B	618.88B	557.64B
Cash Flow
Free Cash Flow	107.83B	97.77B	124.00B	59.27B	70.58B
Operating Cash Flow	137.84B	137.10B	162.41B	92.22B	105.25B
Investing Cash Flow	-58.65B	-73.84B	-67.53B	-7.14B	-79.84B
Financing Cash Flow	-90.84B	-66.79B	-67.01B	-61.65B	-45.18B

Unicharm Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.82
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UNICY, the sentiment is Negative. The current price of 2.82 is below the 20-day moving average (MA) of 3.22, below the 50-day MA of 3.07, and below the 200-day MA of 3.27, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 33.42 is Neutral, neither overbought nor oversold. The STOCH value of 1.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UNICY.

Unicharm Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PG	74 Outperform	$350.11B	20.05	31.23%	2.92%	1.23%	17.97%
CHD	73 Outperform	$23.14B	27.62	17.16%	1.38%	1.45%	42.04%
UNICY	70 Outperform	$10.50B	82.65	11.28%	―	-0.81%	-0.63%
UL	69 Neutral	$139.84B	20.76	26.01%	3.74%	-0.30%	-14.60%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
CL	61 Neutral	$71.21B	-429.64	431.59%	2.67%	-0.05%	2.49%
KMB	61 Neutral	$32.81B	16.63	155.28%	5.03%	-10.04%	-23.41%